The Value of Systematic Biopsies During Vertebroplasty for the Treatment of Osteoporotic Vertebral Fractures
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Myeloma
Related studies linked through entity extraction aliases.
Assessing the Relationship Between Hypoxia and the Immune Environment in Myeloma Patients (CHIME)
- Status
- UNKNOWN
- Phase
- N/A
Multicenter Phase 2 Study of Subcutaneous Isatuximab Plus Bortezomib, Lenalidomide and Dexamethasone in the Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy
- Status
- COMPLETED
- Phase
- NA
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
- Status
- RECRUITING
- Phase
- NA
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
Non-invasive MRD Assessment in Multiple Myeloma
- Status
- COMPLETED
- Phase
- N/A
Understanding Patterns of Fatigue in Health and Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
SABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS-CoV-2 Neutralising Antibodies in High-risk Populations
- Status
- WITHDRAWN
- Phase
- PHASE2
Dual-Energy Computed Tomography for Improving Imaging Assessment of Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.
- Status
- COMPLETED
- Phase
- PHASE2
Continuous Temperature Monitoring for tHe Early Recognition of Febrile Neutropenia in Haematological MALignancies
- Status
- UNKNOWN
- Phase
- N/A
FT576 in Subjects With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy
- Status
- UNKNOWN
- Phase
- N/A
Duvelisib in Combination With BMS-986345 in Lymphoid Malignancy
- Status
- COMPLETED
- Phase
- PHASE1
Removing Transfusion Dependence as a Barrier to Hospice Enrollment
- Status
- COMPLETED
- Phase
- NA
A Phase 1 With Extension Cohort, Single Arm, Single Center, Open Label Trial of Belantamab Mafodotin for the Treatment of High-Risk Smoldering Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
Geriatric-assessment Interventions to Address Functional Deficits in Older Adults w Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA
Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE4